Bioorganic & Medicinal Chemistry Letters | Vol 28, Issue 14, Pages 2343-2576 (1 August 2018) | ScienceDirect.com by Elsevier
Bioorganic & Medicinal Chemistry Letters | Vol 28, Issue 2, Pages 53-230 (15 January 2018) | ScienceDirect.com by Elsevier
![PDF) Corrigendum to “2-Alkyl-4-aryl-pyrimidine fused heterocycles as selective 5-HT2A antagonists” [Bioorg. Med. Chem. Lett. 18 (2008) 2103–2108] | Dale Rudolph - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/47033617/mini_magick20190208-16001-acsyt1.png?1549613596 "PDF) Corrigendum to “2-Alkyl-4-aryl-pyrimidine fused heterocycles as selective 5-HT2A antagonists” [Bioorg. Med. Chem. Lett. 18 (2008) 2103–2108] | Dale Rudolph - Academia.edu")
PDF) Corrigendum to “2-Alkyl-4-aryl-pyrimidine fused heterocycles as selective 5-HT2A antagonists” [Bioorg. Med. Chem. Lett. 18 (2008) 2103–2108] | Dale Rudolph - Academia.edu
Bioorganic & Medicinal Chemistry Letters XXX (2011) XXX-XXX | PDF | Molecules | Chemical Bond
Writing Your Next Medicinal Chemistry Article: Journal Bibliometrics and Guiding Principles for Industrial Authors | Journal of Medicinal Chemistry
Bioorganic medicinal chemistry letters template
Syntrix Publication in Bioorganic & Medicinal Chemistry Letters – Syntrix Pharmaceuticals
Bioorganic & Medicinal Chemistry Letters | Vol 30, Issue 17, 1 September 2020 | ScienceDirect.com by Elsevier
![PDF) Corrigendum to 'Synthesis and biological evaluation of Doxorubicin-containing conjugate targeting PSMA' [Bioor. Med. Chem. Lett. 29/10 (2019) 1246–1255]](https://i1.rgstatic.net/publication/332830620_Corrigendum_to_'Synthesis_and_biological_evaluation_of_Doxorubicin-containing_conjugate_targeting_PSMA'_Bioor_Med_Chem_Lett_2910_2019_1246-1255/links/60084c9192851c13fe2413ca/largepreview.png "PDF) Corrigendum to 'Synthesis and biological evaluation of Doxorubicin-containing conjugate targeting PSMA' [Bioor. Med. Chem. Lett. 29/10 (2019) 1246–1255]")
PDF) Corrigendum to 'Synthesis and biological evaluation of Doxorubicin-containing conjugate targeting PSMA' [Bioor. Med. Chem. Lett. 29/10 (2019) 1246–1255]
Bioorganic & Medicinal Chemistry Letters | Journal | ScienceDirect.com by Elsevier
Bioorganic & Medicinal Chemistry Letters | Vol 33, 1 February 2021 | ScienceDirect.com by Elsevier
PDF) Bioorganic & Medicinal Chemistry Letters 24 (2014) 1209–1213 | Jose A Escario - Academia.edu
![PDF) Corrigendum to “Structure-based design and synthesis of macrocyclic peptidomimetic β-secretase (BACE-1) inhibitors” [Bioorg. Med. Chem. Lett. 19 (2009) 1361–1365] | Ulf Neumann - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/43610754/mini_magick20190215-24458-m15ml6.png?1550286693 "PDF) Corrigendum to “Structure-based design and synthesis of macrocyclic peptidomimetic β-secretase (BACE-1) inhibitors” [Bioorg. Med. Chem. Lett. 19 (2009) 1361–1365] | Ulf Neumann - Academia.edu")
PDF) Corrigendum to “Structure-based design and synthesis of macrocyclic peptidomimetic β-secretase (BACE-1) inhibitors” [Bioorg. Med. Chem. Lett. 19 (2009) 1361–1365] | Ulf Neumann - Academia.edu
![PDF) Corrigendum to “New PPARγ ligands based on barbituric acid: Virtual screening, synthesis and receptor binding studies” [Bioorg. Med. Chem. Lett. 18 (2008) 4959]](https://i1.rgstatic.net/publication/257419056_Corrigendum_to_New_PPARg_ligands_based_on_barbituric_acid_Virtual_screening_synthesis_and_receptor_binding_studies_Bioorg_Med_Chem_Lett_18_2008_4959/links/59f4a712458515547c21c6df/largepreview.png "PDF) Corrigendum to “New PPARγ ligands based on barbituric acid: Virtual screening, synthesis and receptor binding studies” [Bioorg. Med. Chem. Lett. 18 (2008) 4959]")
PDF) Corrigendum to “New PPARγ ligands based on barbituric acid: Virtual screening, synthesis and receptor binding studies” [Bioorg. Med. Chem. Lett. 18 (2008) 4959]
Bioorganic & Medicinal Chemistry template - For Authors
Bioorganic & Medicinal Chemistry Letters | Vol 26, Issue 17, Pages 4157-4386 (1 September 2016) | ScienceDirect.com by Elsevier
Bioorganic and Medicinal Chemistry Letters | Scholars Portal Journals
This article was originally published in a journal published by Elsevier, and the attached copy is provided by Elsevier for the
Bioorganic & Medicinal Chemistry Letters
![PDF) Corrigendum to “Novel indole-3-sulfonamides as potent HIV non-nucleoside reverse transcriptase inhibitors (NNRTIs)” [Bioorg. Med. Chem. Lett. (2008) 554] | Joseph Vacca and Georgia McGaughey - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/42029221/mini_magick20190218-15107-4ct7rc.png?1550499632 "PDF) Corrigendum to “Novel indole-3-sulfonamides as potent HIV non-nucleoside reverse transcriptase inhibitors (NNRTIs)” [Bioorg. Med. Chem. Lett. (2008) 554] | Joseph Vacca and Georgia McGaughey - Academia.edu")
PDF) Corrigendum to “Novel indole-3-sulfonamides as potent HIV non-nucleoside reverse transcriptase inhibitors (NNRTIs)” [Bioorg. Med. Chem. Lett. (2008) 554] | Joseph Vacca and Georgia McGaughey - Academia.edu
Bioorganic & Medicinal Chemistry Letters | Vol 30, Issue 22, 15 November 2020 | ScienceDirect.com by Elsevier
![PDF) Erratum to “Inhibitors of potassium channels KV1.3 and IK-1 as immunosuppressants” [Bioorg. Med. Chem. Lett. 19 (2009) 2299–2304] | Stephan Grissmer - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/42665312/mini_magick20190217-8886-1ojl54i.png?1550420382 "PDF) Erratum to “Inhibitors of potassium channels KV1.3 and IK-1 as immunosuppressants” [Bioorg. Med. Chem. Lett. 19 (2009) 2299–2304] | Stephan Grissmer - Academia.edu")
PDF) Erratum to “Inhibitors of potassium channels KV1.3 and IK-1 as immunosuppressants” [Bioorg. Med. Chem. Lett. 19 (2009) 2299–2304] | Stephan Grissmer - Academia.edu
Bioorganic & Medicinal Chemistry Letters | Vol 23, Issue 1, Pages 1-382 (1 January 2013) | ScienceDirect.com by Elsevier
Fragment-to-Lead Medicinal Chemistry Publications in 2017 | Journal of Medicinal Chemistry
